ResMed
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
9001 Spectrum Center Blvd, San Diego, Ca...Phone Number
(858) 836-5000Website
www.resmed.comRevenue
$5.5 BillionStock Symbol
RMDIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
11
11
1
2
2
2
About ResMed
Founded in 1989, ResMed participates in the development, manufacturing, and marketing of innovative medical products for the treatment and management of respiratory disorders with a focus on sleep-disordered breathing.Explore more
ResMed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ResMed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ResMed recently announced quarterly report
Check if ResMed has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at ResMed
Click to see if ResMed had a recent Job posting/layoffs
Product Launch: Get notified when ResMed launches new products
Check out if ResMed is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once ResMed has new funding data
ResMed, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined ResMed as Masked Content
Find more new buyers
Compare Similar Companies to ResMed
Compare insights from companies similar to ResMed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Compare CEO
How does Michael Farrell compare against Competing Companies' CEOs?
Michael Farrell
Chief Executive Officer & Chairman of the Boa...
Top 5%
CEO effectiveness to drive business results
Excellent
60%
Good
20%
Average
20%
Poor
0%
Very Bad
0%
Good
100%Bad
0%VS.
Top 5%
CEO effectiveness to drive business results
Excellent
0%
Good
100%
Average
0%
Poor
0%
Very Bad
0%
Good
100%Bad
0%Lewis Gradon
CEO at Fisher & Paykel Healthc...
Scott Reese
CEO at GE Digital
Company Profile Activity
Activity Insights
ResMed is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ResMed is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ResMed.
ResMed financials insights
Gather financial insights about ResMed, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1995
Stock Offering
$18.9M
ResMed Tech Stack
A closer look at the technologies used by ResMed
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
ResMed News & Media
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
Angelini Ventures marks its first portfolio exit as ResMed acquires Noctrix Health, validating its strategy of backing breakthrough healthcare innovation.ResMed Inc. (RMD) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript
ResMed Inc. (RMD) 46th Annual William Blair Growth Stock Conference June 2, 2026 5:40 PM EDTCompany ParticipantsMichael Farrell - CEO &...Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
Acquisition adds Nidra® Tonic Motor Activation (TOMAC) Therapy, an FDA De Novo classified, nonpharmacologic treatment designed to address moderate-to-severe Restless Legs Syndrome (RLS). Acquisition adds Nidra® Tonic Motor Activation (TOMAC) Therapy, an FDA De Novo classified, nonpharmacologic treatment designed to address moderate-to-severe Restless Legs Syndrome (RLS).Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 46th Annual William Blair Growth Stock Conference in Chicago, IL on Tuesday, June 2, 2026. Resmed’s webcast presentation will begin at approximately 4:40 p.m. (Central Time).
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ResMed
Sign Up For FreeTo access detailed company insights
Founded in 1989, ResMed participates in the development, manufacturing, and marketing of innovative medical products for the treatment and management of respiratory disorders with a focus on sleep-disordered breathing.... Read More
